The final clinical trial of the coronavirus vaccine of Oxford University and AstraZeneca has been postponed. The decision was made after one of the vaccinators fell ill. The BBC published this news on Wednesday (September 9) morning. Astageneca described it as a 'routine' break.

According to the BBC, the event was temporarily suspended after a volunteer fell ill during the trial, but the man's identity was not revealed. No details were available about the nature of his illness. However, he has been kept under observation. Authorities say trials of the vaccine will be closed worldwide until details of the man's illness are known. However, it is hoped that the person will recover quickly.

There are several corona ticker trials around the world. Leading the way was the vaccine, a joint venture between Astageneca and Oxford. So the whole world was focused on the final trial process of this tick.

This vaccine may be one of the first vaccines to come on the market. So after the first and second phase trials, everyone's expectations were skyrocketing with this vaccine. Recently, the trial of the third phase of this vaccine was started. About 30,000 people from Britain, Brazil, the United States and South Africa took part in it.

The trial is set to begin soon, according to AstraZeneca, a British pharmaceutical company that is a marketing partner of Oxford Ticker. The organization says such cases are not new to large-scale clinical trials. This is a kind of routine work.

Incidentally, the third phase of the trial is usually attended by thousands of people and the trial lasts for several years.